Learn More
Medchemexpress LLC Teneligliptin hydrobromide hydrate | 1572583-29-9 | 99.97% | 426.58 | 25 MG

Supplier: Medchemexpress LLC 25MGHY14806B
Teneligliptin hydrobromide hydrate is an orally active and selective dipeptidyl peptidase 4 (DPP-4) inhibitor with IC50s of 0.37 and 0.29 nM for human and rat DPP-4, respectively. It improves blood glucose levels and is utilized in research related to type 2 diabetes mellitus.
- Prevents activation of NLRP3 inflammasome and injury in primary mouse cardiomyocytes
- Protects against hypoxia/reoxygenation-induced endothelial cell injury
- Inhibits inflammation and apoptosis in H9c2 cells
- Attenuates myocardial hypertrophy and injury in diabetic cardiomyopathy mice
- Prevents obesity and related manifestations in high-fat diet-induced obesity models
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.